vaccine Archives - Latest News | Global Business Review Magazines

Study finds that School Vaccine Mandates are being opposed

Posted on December 17, 2022 by Admin

A new survey released Friday by the Kaiser Family Foundation said that 35 percent of parents oppose requirements that children receive routine immunizations in order to attend school but in past For generations of most American families, getting children vaccinated was just something to check off on the list of back-to-school chores.

According to New York Times, “Throughout the pandemic, the Kaiser foundation, a nonpartisan health care research organization, has been issuing monthly reports on changing attitudes toward Covid vaccines. The surveys have showed a growing political divide over the issue, and the latest study indicates that division now extends to routine childhood vaccinations.

Forty-four percent of adults who either identify as Republicans or lean that way said in the latest survey that parents should have the right to opt out of school vaccine mandates, up from 20 percent in a prepandemic poll conducted in 2019 by the Pew Research Center. In contrast, 88 percent of adults who identify as or lean Democratic endorsed childhood vaccine requirements, a slight increase from 86 percent in 2019.”

The survey

About the survey they said, “The survey found that 28 percent of adults overall believed parents should have the authority to make school vaccine decisions for their children, a stance that in the 2019 Pew poll was held by just 16 percent of adults.

The shift in positions appears to be less about rejecting the shots than a growing endorsement of the so-called parents’ rights movement. Indeed, 80 percent of parents said that the benefits of vaccines for measles, mumps and rubella outweighed the risks, down only slightly from 83 percent in 2019.”

“The talking point that has been circulated is the concept of taking away parents’ rights,” said Dr. Sean O’Leary, chairman of the American Academy of Pediatrics’ committee on infectious diseases. “And when you frame it that simply, it’s very appealing to a certain segment of the population. But what about the right to have your children be safe in school from vaccine-preventable diseases?”

For more updates on legal industry, click here.

Pfizer Inc. and BioNTech signed a $3.2 billion deal with the U.S. government

Posted on June 30, 2022 by Admin

Pfizer Inc. and their partner BioNTech made an announcement on Wednesday that they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine. They are also set to deliver the Vaccines by this summer’s last only.

What does the new $3.2 billion deal include?

According to Pfizer, the $3.2 billion deal includes supplies of a retooled omicron-adapted vaccine, pending regulatory clearance. Drugmakers have been developing vaccines to target the omicron variant that became dominant last winter. In the new deal, the average price per dose is over $30, a more than 50% increase from the $19.50 per dose the U.S. government paid in its initial contract with Pfizer. Some of the vaccines included in the contract will be embarked for adults and will be of single dose.

U.S. Department of Health and Human Services official Dawn O’Connell said in a statement, “We look forward to taking delivery of these new variant-specific vaccines and working with state and local health departments, pharmacies, healthcare providers, federally qualified health centers, and other partners to make them available in communities around the country this fall,”

Change of COVID-19 Boosters

U.S. Food and Drug Administration advisers on Tuesday recommended a change in the design of COVID-19 booster shots for this fall in order to combat more recently circulating variants of the coronavirus.

According to a report by Reuters, “The U.S. government has distributed close to 450 million doses of the Pfizer/BioNTech vaccine in the United States since it was first authorized in December 2020, according to data from the U.S. Centers for Disease Control and Prevention. Over 350 million of those doses have been administered.

Because the Biden administration was unable to line up more COVID-19 funding from Congress earlier this month, it was forced to reallocate $10 billion of existing funding to pay for additional vaccines and treatments.”

FDA says yes to Covid-19 Vaccines for Young Children

Posted on June 17, 2022 by Admin

FDA gives green signal for COVID-19 vaccines young children under the age of 5 years and as young as 6 months are going to get their Covid-19 Vaccine shots. FDA (US Food and Drug Administration) members collectively agreed on the decision that vaccines from Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N)/BioNTech SE (22UAy.DE) can be used for even the youngest American children by answering yes to the question, “Based on the totality of scientific evidence available, do the benefits of the Moderna COVID-19 Vaccine when administered as a 2-dose series (25 micrograms each dose) outweigh its risks for use in infants and children 6 months through 5 years of age?” Moreover they replied in the affirmative to this as well-, “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine when administered as a 3-dose series (3 micrograms each dose) outweigh its risks for use in infants and children 6 months through 4 years of age?”

Why is Vaccines for Young Children is Necessary?

Vaccines for Young Children is indeed necessary. Though the disease is less effective in children, FDA official Peter Marks to the panel said, “I think we have to be careful that we don’t become numb to the number of pediatric deaths because of the overwhelming number of older deaths,” Reingold, of the University of California, Berkeley said, “If we have a vaccine with benefits that outweigh the risks, then making it available to people is a reasonable choice,”

Expert’s suggestion

Speaking of the necessity of vaccines for young children, an associate professor of microbiology and immunology at the University of Michigan Medical School Oveta Fuller about Moderna vaccine, “The benefits seem to clearly outweigh the risks, particularly for those with young children who may be in kindergarten or in collective child care,”

Symptoms seen after shots

Dr. Rituparna Das, Moderna’s vice president of Covid-19 vaccines clinical development said, “Pain was the most common event,” She added, “Young children’s events included fever, headache, fatigue, myalgia, arthralgia, nausea, vomiting and chills. For infants and toddlers, events included fever, irritability, crying, sleepiness and loss of appetite.”

J&J and Emergent end agreement on Covid-19 Vaccine manufacturing

Posted on June 16, 2022 by Admin

Manufacturing of Covid-19 Vaccination doses is one of the most important issues in the world of pharmaceutical companies these days. Some of the leading companies in this field are continuously trying their best to meet the rising global demand. At this high time, Johnson and Johnson and Emergent BioSolutions Inc Monday came to a decision to terminate their agreement to make the doses of Covid-19 Vaccine.

What is Emergent saying?

According to Emergent Johnson and Johnson failed to buy the minimum quantity of COVID-19 vaccines made by the company. They added that while failing to fulfill the minimum requirements of the agreement Johnson and Johnson the American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods, has also failed to provide required forecasts for the number of vaccines it needed.

What are Johnson and Johnson saying?

On the other hand, Johnson and Johnson stated that the information provided by Emergent BioSolutions is “false and misleading”. According to them they have sufficient capacity across their global COVID-19 vaccine manufacturing network and can continue to meet their contractual obligations to supply vaccine.

Emergent’s Baltimore plant paused the manufacturing of doses last year after they got to know that ingredients from AstraZeneca’s COVID-19 vaccine, also being produced there at that time, contaminated a batch of J&J’s vaccines. The contamination resulted in the destruction of key ingredients that would have amounted to roughly 400 million doses of COVID-19 vaccines from J&J and AstraZeneca. Added to that due to safety concerns the use of the COVID-19 Vaccine produced by Johnson and Johnson has been restricted by the Food and Drug Administration of the United States in May.

Closure of the Agreement

At first, J&J provided formal notice of termination and breach to Emergen. Eventually, Emergent BioSolutions said in a securities filing that it had sent a notice of material breach of the agreement to J&J.

Tag: vaccine